Which ETFs hold Ascendis Pharma A/S?

61 thematic and core ETFs hold Ascendis Pharma A/S, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are MEDI at 13.61% of the fund on Jul 31, 2026, FPXE at 6.06% of the fund on Nov 3, 2026 and AFOS at 3.47% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart.

Company · ASND · listed in DK

ETFs that hold Ascendis Pharma A/S

Share on X Download as PDF

61 thematic and core ETFs hold Ascendis Pharma A/S, by holdings dated Jun 30, 2026 to Nov 3, 2026. MEDI holds the most, at 13.61% of the fund on Jul 31, 2026. The next largest are FPXE (6.06%) and AFOS (3.47%).

askIQ about this page

askIQ about Ascendis Pharma A/S

1 income and other fund on it is listed below.

Look up another company askIQ about who holds ASND

Share of each fund · one bar per fund, largest first

MEDI 13.61%61 fundsIWD <0.01%

funds above 10%

0.10%

median share

funds under 1%

Thematic and core funds that hold it

61 funds

50 of 61 · click a column to sort

ETFs that hold Ascendis Pharma A/S
#	Fund	Name	Share of the fund ↓	Holdings filed	Asset
1	MEDI	Harbor Health Care ETF	13.61%	Jul 31, 2026	Equity
2	FPXE	First Trust IPOX Europe Equity Opportunities ETF	6.06%	Nov 3, 2026	Equity
3	AFOS	ARS Focused Opportunities Strategy ETF	3.47%	Aug 31, 2026	Equity
4	AADR	AdvisorShares Dorsey Wright ADR ETF	3.19%	Jun 30, 2026	Equity
5	FDG	American Century Focused Dynamic Growth ETF	2.72%	Aug 31, 2026	Equity
6	SQS	Sapient Quality Select ETF	2.63%	Jul 31, 2026	Equity
7	EXUS	Nomura Focused International Core ETF	2.21%	Jun 30, 2026	Equity
8	FMED	Fidelity Disruptive Medicine ETF	1.97%	Aug 31, 2026	Equity
9	TMED	T. Rowe Price Health Care ETF	1.60%	Jun 30, 2026	Equity
10	BBP	Virtus Biotech ETF	1.54%	Jul 31, 2026	Equity
11	FXH	First Trust Health Care AlphaDEX Fund	1.38%	Nov 3, 2026	Equity
12	TCAF	T. Rowe Price Capital Appreciation Equity ETF	1.26%	Jun 30, 2026	Equity
13	FFOG	Franklin Focused Growth ETF	1.12%	Jun 30, 2026	Equity
14	ILDR	First Trust Innovation Leaders ETF	1.07%	Nov 3, 2026	Equity
15	IBB	iShares Biotechnology ETF	1.06%	Nov 3, 2026	Equity
16	IBBQ	Invesco Nasdaq Biotechnology ETF	0.99%	Nov 3, 2026	Equity
17	MSSM	Morgan Stanley Pathway Small-Mid Cap Equity ETF	0.89%	Aug 31, 2026	Equity
18	QQQJ	Invesco NASDAQ Next Gen 100 ETF	0.78%	Nov 3, 2026	Equity
19	IWP	iShares Russell Mid-Cap Growth ETF	0.38%	Nov 3, 2026	Equity
20	TMSL	T. Rowe Price Small-Mid Cap ETF	0.35%	Jun 30, 2026	Equity
21	WDAI	Pacer S&P World 3AI Top 300 ETF	0.33%	Jul 31, 2026	Equity
22	ESIM	Eventide International ETF	0.29%	Jul 31, 2026	Equity
23	IDHQ	Invesco S&P International Developed Quality ETF	0.26%	Nov 3, 2026	Equity
24	MSLC	Morgan Stanley Pathway Large Cap Equity ETF	0.25%	Aug 31, 2026	Equity
25	TNXT	T. Rowe Price Innovation Leaders ETF	0.23%	Jun 30, 2026	Equity
26	IYH	iShares U.S. Healthcare ETF	0.19%	Nov 3, 2026	Equity
27	SMMD	iShares Russell 2500 ETF	0.19%	Nov 3, 2026	Equity
28	QQHG	Invesco QQQ Hedged Advantage ETF	0.15%	Nov 3, 2026	Equity
29	RUSC	Russell Investments U.S. Small Cap Equity ETF	0.12%	Jun 30, 2026	Equity
30	REMC	Columbia Research Enhanced Mid Cap ETF	0.12%	Jun 30, 2026	Equity
31	IWR	iShares Russell Mid-Cap ETF	0.10%	Nov 3, 2026	Equity
32	EQAL	Invesco Russell 1000 Equal Weight ETF	0.09%	Nov 3, 2026	Equity
33	GSWO	Goldman Sachs ActiveBeta World Equity ETF	0.09%	Aug 31, 2026	Equity
34	IQSI	NYLIM Candriam International Equity ETF	0.08%	Jul 31, 2026	Equity
35	VFMO	Vanguard U.S. Momentum Factor ETF	0.08%	Sep 30, 2026	Equity
36	GSID	Goldman Sachs MarketBeta International Equity ETF	0.06%	Aug 31, 2026	Equity
37	MNZL	Manzil Russell Halal USA Broad Market ETF	0.05%	Jul 31, 2026	Equity
38	VDG	Vanguard Developed Markets ex-US Growth Index ETF	0.05%	Sep 30, 2026	Equity
39	BKIE	BNY Mellon International Equity ETF	0.04%	Jul 31, 2026	Equity
40	GGUS	Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF	0.04%	Aug 31, 2026	Equity
41	IWF	iShares Russell 1000 Growth ETF	0.04%	Nov 3, 2026	Equity
42	SPDW	State Street SPDR Portfolio Developed World ex-US ETF	0.04%	Nov 3, 2026	Equity
43	VDV	Vanguard Developed Markets ex-US Value Index ETF	0.04%	Sep 30, 2026	Equity
44	ONEQ	Fidelity Nasdaq Composite Index ETF	0.04%	Aug 31, 2026	Equity
45	VONG	Vanguard Russell 1000 Growth ETF	0.03%	Sep 30, 2026	Equity
46	GXUS	Goldman Sachs MarketBeta Total International Equity ETF	0.03%	Aug 31, 2026	Equity
47	AVUQ	Avantis U.S. Quality ETF	0.03%	Nov 2, 2026	Equity
48	ONEO	State Street SPDR Russell 1000 Momentum Focus ETF	0.03%	Nov 3, 2026	Equity
49	IWB	iShares Russell 1000 ETF	0.02%	Nov 3, 2026	Equity
50	IWV	iShares Russell 3000 ETF	0.02%	Nov 3, 2026	Equity
51	RECS	Columbia Research Enhanced Core ETF	0.02%	Jul 31, 2026	Equity
52	VONE	Vanguard Russell 1000 ETF	0.02%	Sep 30, 2026	Equity
53	VTHR	Vanguard Russell 3000 ETF	0.02%	Sep 30, 2026	Equity
54	OMFL	Invesco Russell 1000 Dynamic Multifactor ETF	0.01%	Nov 3, 2026	Equity
55	VT	Vanguard Total World Stock Index ETF	0.01%	Sep 30, 2026	Equity
56	DEUS	Xtrackers Russell US Multifactor ETF	0.01%	Aug 31, 2026	Equity
57	IWS	iShares Russell Mid-Cap Value ETF	0.01%	Nov 3, 2026	Equity
58	FBCG	Fidelity Blue Chip Growth ETF	0.01%	Jul 31, 2026	Equity
59	REVS	Columbia Research Enhanced Value ETF	<0.01%	Jul 31, 2026	Equity
60	VONV	Vanguard Russell 1000 Value ETF	<0.01%	Sep 30, 2026	Equity
61	IWD	iShares Russell 1000 Value ETF	<0.01%	Nov 3, 2026	Equity

As of Nov 5, 2026. Source: each fund's own holdings.

Income and other funds that hold it

#	Fund	Name	Share of the fund	Holdings filed	Category
1	TCAL	T. Rowe Price Capital Appreciation Premium Income ETF	0.56%	Jun 30, 2026	Income

As of Nov 5, 2026. Source: each fund's own holdings.

How we count

Ascendis Pharma A/S (ticker ASND, listed in DK) is matched in every holdings book ETFIQ publishes, by its ticker and name.

Amber dates are more than a quarter old; the fund may have traded since.

How books are read →

Where to next

Look up another company→

Themes that hold it: Broad innovation and megatrends, Biotech→

See what a portfolio holds, company by company→

Questions people ask

Which ETFs hold Ascendis Pharma A/S?: 61 thematic and core ETFs hold Ascendis Pharma A/S, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are MEDI at 13.61% of the fund on Jul 31, 2026, FPXE at 6.06% of the fund on Nov 3, 2026 and AFOS at 3.47% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart.

Sources and dates

HoldingsSEC Form N-PORT, what a fund filed it holds ↗

FilingsSEC EDGAR, full-text search of fund filings ↗

Links go to the source documents. ETFIQ is an independent publisher and makes no recommendations. Standards and sources →

Cite this pageCitation, APA and Markdown

ETFIQ, ETFs holding ASCENDIS PHARMA A/S, data as of Nov 5, 2026. https://etfiq.com/holdings/asnd/

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.

.dc-more{display:revert!important}.dc-more[style^="display:flex"]{display:flex!important}.dc-more[style^="display:grid"]{display:grid!important}[data-show-all],[data-show-all-idx]{display:none!important}